NOT-CA-20-067: Notice of Correction to Application Types Allowed for PAR-20-053, Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection (R01 Clinical Trial Not Allowed)

Notice of Correction to Application Types Allowed for PAR-20-053, Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection (R01 Clinical Trial Not Allowed)

Notice Number:

NOT-CA-20-067

Key Dates

Release Date:

Related Announcements

PAR-20-053

Issued by

National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to correct the Application Types Allowed for PAR-20-053, Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection (R01 Clinical Trial Not Allowed).

The following sections of PAR-20-053 are being corrected:

Part 2. Full Text of Announcement, Section II. Award Information

Application Types Allowed

Currently reads:

New
Resubmission
Revision

Should correctly read (in italics)

New
Renewal
Resubmission
Revision

All other aspects of the FOA are unchanged.

Inquiries

Please direct all inquiries to:

Scientific/Research Contact(s)

Sudhir Srivastava, Ph.D., M.P.H
National Cancer Institute (NCI)
Telephone: 240-276-7028
Email: srivasts@mail.nih.gov

Matthew Young, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-8546
Email: youngma@mail.nih.gov